ID:EGFR_HUMAN DESCRIPTION: RecName: Full=Epidermal growth factor receptor; EC=2.7.10.1; AltName: Full=Proto-oncogene c-ErbB-1; AltName: Full=Receptor tyrosine-protein kinase erbB-1; Flags: Precursor; FUNCTION: Receptor tyrosine kinase binding ligands of the EGF family and activating several signaling cascades to convert extracellular cues into appropriate cellular responses. Known ligands include EGF, TGFA/TGF-alpha, amphiregulin, epigen/EPGN, BTC/betacellulin, epiregulin/EREG and HBEGF/heparin-binding EGF. Ligand binding triggers receptor homo- and/or heterodimerization and autophosphorylation on key cytoplasmic residues. The phosphorylated receptor recruits adapter proteins like GRB2 which in turn activates complex downstream signaling cascades. Activates at least 4 major downstream signaling cascades including the RAS- RAF-MEK-ERK, PI3 kinase-AKT, PLCgamma-PKC and STATs modules. May also activate the NF-kappa-B signaling cascade. Also directly phosphorylates other proteins like RGS16, activating its GTPase activity and probably coupling the EGF receptor signaling to the G protein-coupled receptor signaling. Also phosphorylates MUC1 and increases its interaction with SRC and CTNNB1/beta-catenin. FUNCTION: Isoform 2 may act as an antagonist of EGF action. CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate. ENZYME REGULATION: Endocytosis and inhibition of the activated EGFR by phosphatases like PTPRJ and PTPRK constitute immediate regulatory mechanisms. Upon EGF-binding phosphorylates EPS15 that regulates EGFR endocytosis and activity. Moreover, inducible feedback inhibitors including LRIG1, SOCS4, SOCS5 and ERRFI1 constitute alternative regulatory mechanisms for the EGFR signaling. SUBUNIT: Binding of the ligand triggers homo- and/or heterodimerization of the receptor triggering its autophosphorylation. Heterodimer with ERBB2. Interacts with ERRFI1; inhibits dimerization of the kinase domain and autophosphorylation. Part of a complex with ERBB2 and either PIK3C2A or PIK3C2B. Interacts with GRB2; an adapter protein coupling the receptor to downstream signaling pathways. Interacts with GAB2; involved in signaling downstream of EGFR. Interacts with STAT3; mediates EGFR downstream signaling in cell proliferation. Interacts with RIPK1; involved in NF-kappa-B activation. Interacts (autophosphorylated) with CBL; involved in EGFR ubiquitination and regulation. Interacts with SOCS5; regulates EGFR degradation through TCEB1- and TCEB2-mediated ubiquitination and proteasomal degradation. Interacts with PRMT5; methylates EGFR and enhances interaction with PTPN6. Interacts (phosphorylated) with PTPN6; inhibits EGFR-dependent activation of MAPK/ERK. Interacts with COPG1; essential for regulation of EGF- dependent nuclear transport of EGFR by retrograde trafficking from the Golgi to the ER. Interacts with TNK2; this interaction is dependent on EGF stimulation and kinase activity of EGFR. Interacts with PCNA; positively regulates PCNA. Interacts with PELP1. Interacts with MUC1. Interacts with AP2M1. Interacts with FER. May interact with EPS8; mediates EPS8 phosphorylation. Interacts (via SH2 domains) with GRB2, NCK1 and NCK2. Interacts with ATX2. INTERACTION: Self; NbExp=13; IntAct=EBI-297353, EBI-297353; Q02952:AKAP12; NbExp=2; IntAct=EBI-297353, EBI-2562430; P62158:CALM3; NbExp=3; IntAct=EBI-297353, EBI-397435; P62161:Calm3 (xeno); NbExp=6; IntAct=EBI-297353, EBI-397530; P22681:CBL; NbExp=4; IntAct=EBI-297353, EBI-518228; P22682:Cbl (xeno); NbExp=2; IntAct=EBI-297353, EBI-640919; Q99418:CYTH2; NbExp=5; IntAct=EBI-297353, EBI-448974; P01133:EGF; NbExp=3; IntAct=EBI-297353, EBI-640857; P04626:ERBB2; NbExp=9; IntAct=EBI-297353, EBI-641062; P21860:ERBB3; NbExp=6; IntAct=EBI-297353, EBI-720706; Q15303:ERBB4; NbExp=2; IntAct=EBI-297353, EBI-80371; Q9UJM3:ERRFI1; NbExp=2; IntAct=EBI-297353, EBI-2941912; P03372-4:ESR1; NbExp=4; IntAct=EBI-297353, EBI-4309277; Q14318:FKBP8; NbExp=3; IntAct=EBI-297353, EBI-724839; P60520:GABARAPL2; NbExp=2; IntAct=EBI-297353, EBI-720116; P04406:GAPDH; NbExp=4; IntAct=EBI-297353, EBI-354056; P62993:GRB2; NbExp=12; IntAct=EBI-297353, EBI-401755; Q9UBN7:HDAC6; NbExp=8; IntAct=EBI-297353, EBI-301697; P08107:HSPA1B; NbExp=4; IntAct=EBI-297353, EBI-629985; P46940:IQGAP1; NbExp=4; IntAct=EBI-297353, EBI-297509; Q9Y2H9:MAST1; NbExp=2; IntAct=EBI-297353, EBI-3385920; P08581:MET; NbExp=4; IntAct=EBI-297353, EBI-1039152; O00750:PIK3C2B; NbExp=7; IntAct=EBI-297353, EBI-641107; Q9UJ41:RABGEF1; NbExp=4; IntAct=EBI-297353, EBI-913954; Q13671:RIN1; NbExp=3; IntAct=EBI-297353, EBI-366017; Q01973:ROR1; NbExp=8; IntAct=EBI-297353, EBI-6082337; P29353:SHC1; NbExp=5; IntAct=EBI-297353, EBI-78835; P13866:SLC5A1; NbExp=3; IntAct=EBI-297353, EBI-1772443; P12931:SRC; NbExp=5; IntAct=EBI-297353, EBI-621482; P31948:STIP1; NbExp=2; IntAct=EBI-297353, EBI-1054052; Q8K424:Trpv3 (xeno); NbExp=2; IntAct=EBI-297353, EBI-2650739; P09936:UCHL1; NbExp=2; IntAct=EBI-297353, EBI-714860; Q9P0L0:VAPA; NbExp=2; IntAct=EBI-297353, EBI-1059156; P27348:YWHAQ; NbExp=4; IntAct=EBI-297353, EBI-359854; P63104:YWHAZ; NbExp=4; IntAct=EBI-297353, EBI-347088; SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane protein. Endoplasmic reticulum membrane; Single-pass type I membrane protein. Golgi apparatus membrane; Single-pass type I membrane protein. Nucleus membrane; Single-pass type I membrane protein. Endosome. Endosome membrane. Note=In response to EGF, translocated from the cell membrane to the nucleus via Golgi and ER. Endocytosed upon activation by ligand. SUBCELLULAR LOCATION: Isoform 2: Secreted. TISSUE SPECIFICITY: Ubiquitously expressed. Isoform 2 is also expressed in ovarian cancers. PTM: Phosphorylation at Ser-695 is partial and occurs only if Thr- 693 is phosphorylated. Phosphorylation at Thr-678 and Thr-693 by PRKD1 inhibits EGF-induced MAPK8/JNK1 activation. Dephosphorylation by PTPRJ prevents endocytosis and stabilizes the receptor at the plasma membrane. Autophosphorylation at Tyr-1197 is stimulated by methylation at Arg-1199 and enhances interaction with PTPN6. Autophosphorylation at Tyr-1092 and/or Tyr-1110 recruits STAT3. PTM: Monoubiquitinated and polyubiquitinated upon EGF stimulation; which does not affect tyrosine kinase activity or signaling capacity but may play a role in lysosomal targeting. Polyubiquitin linkage is mainly through 'Lys-63', but linkage through 'Lys-48', 'Lys-11' and 'Lys-29' also occur. PTM: Methylated. Methylation at Arg-1199 by PRMT5 positively stimulates phosphorylation at Tyr-1197. DISEASE: Defects in EGFR are associated with lung cancer (LNCR) [MIM:211980]. LNCR is a common malignancy affecting tissues of the lung. The most common form of lung cancer is non-small cell lung cancer (NSCLC) that can be divided into 3 major histologic subtypes: squamous cell carcinoma, adenocarcinoma, and large cell lung cancer. NSCLC is often diagnosed at an advanced stage and has a poor prognosis. SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein kinase family. EGF receptor subfamily. SIMILARITY: Contains 1 protein kinase domain. WEB RESOURCE: Name=GeneReviews; URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/EGFR"; WEB RESOURCE: Name=NIEHS-SNPs; URL="http://egp.gs.washington.edu/data/egfr/"; WEB RESOURCE: Name=Wikipedia; Note=EGFR entry; URL="http://en.wikipedia.org/wiki/Epidermal_growth_factor_receptor";
The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.
ModBase Predicted Comparative 3D Structure on P00533
Front
Top
Side
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.
Orthologous Genes in Other Species
Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
Biological Process: GO:0000165 MAPK cascade GO:0000186 activation of MAPKK activity GO:0000902 cell morphogenesis GO:0001503 ossification GO:0001889 liver development GO:0001892 embryonic placenta development GO:0001934 positive regulation of protein phosphorylation GO:0001942 hair follicle development GO:0006357 regulation of transcription from RNA polymerase II promoter GO:0006412 translation GO:0006468 protein phosphorylation GO:0006970 response to osmotic stress GO:0006979 response to oxidative stress GO:0007165 signal transduction GO:0007166 cell surface receptor signaling pathway GO:0007169 transmembrane receptor protein tyrosine kinase signaling pathway GO:0007173 epidermal growth factor receptor signaling pathway GO:0007202 activation of phospholipase C activity GO:0007275 multicellular organism development GO:0007435 salivary gland morphogenesis GO:0007494 midgut development GO:0007611 learning or memory GO:0007623 circadian rhythm GO:0008283 cell proliferation GO:0008284 positive regulation of cell proliferation GO:0008544 epidermis development GO:0010750 positive regulation of nitric oxide mediated signal transduction GO:0010960 magnesium ion homeostasis GO:0014066 regulation of phosphatidylinositol 3-kinase signaling GO:0014070 response to organic cyclic compound GO:0016101 diterpenoid metabolic process GO:0016310 phosphorylation GO:0018108 peptidyl-tyrosine phosphorylation GO:0021795 cerebral cortex cell migration GO:0030307 positive regulation of cell growth GO:0030324 lung development GO:0030335 positive regulation of cell migration GO:0031659 positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle GO:0032355 response to estradiol GO:0032930 positive regulation of superoxide anion generation GO:0033138 positive regulation of peptidyl-serine phosphorylation GO:0033590 response to cobalamin GO:0033594 response to hydroxyisoflavone GO:0033993 response to lipid GO:0034614 cellular response to reactive oxygen species GO:0035556 intracellular signal transduction GO:0035690 cellular response to drug GO:0038083 peptidyl-tyrosine autophosphorylation GO:0038128 ERBB2 signaling pathway GO:0042059 negative regulation of epidermal growth factor receptor signaling pathway GO:0042060 wound healing GO:0042127 regulation of cell proliferation GO:0042177 negative regulation of protein catabolic process GO:0042327 positive regulation of phosphorylation GO:0042698 ovulation cycle GO:0042743 hydrogen peroxide metabolic process GO:0043006 activation of phospholipase A2 activity by calcium-mediated signaling GO:0043066 negative regulation of apoptotic process GO:0043406 positive regulation of MAP kinase activity GO:0043586 tongue development GO:0045739 positive regulation of DNA repair GO:0045740 positive regulation of DNA replication GO:0045746 negative regulation of Notch signaling pathway GO:0045780 positive regulation of bone resorption GO:0045893 positive regulation of transcription, DNA-templated GO:0045907 positive regulation of vasoconstriction GO:0045930 negative regulation of mitotic cell cycle GO:0045944 positive regulation of transcription from RNA polymerase II promoter GO:0046328 regulation of JNK cascade GO:0046718 viral entry into host cell GO:0046777 protein autophosphorylation GO:0046854 phosphatidylinositol phosphorylation GO:0048143 astrocyte activation GO:0048146 positive regulation of fibroblast proliferation GO:0048546 digestive tract morphogenesis GO:0048661 positive regulation of smooth muscle cell proliferation GO:0048812 neuron projection morphogenesis GO:0050679 positive regulation of epithelial cell proliferation GO:0050729 positive regulation of inflammatory response GO:0050730 regulation of peptidyl-tyrosine phosphorylation GO:0050999 regulation of nitric-oxide synthase activity GO:0051205 protein insertion into membrane GO:0051592 response to calcium ion GO:0051897 positive regulation of protein kinase B signaling GO:0051968 positive regulation of synaptic transmission, glutamatergic GO:0060571 morphogenesis of an epithelial fold GO:0061024 membrane organization GO:0061029 eyelid development in camera-type eye GO:0070141 response to UV-A GO:0070372 regulation of ERK1 and ERK2 cascade GO:0070374 positive regulation of ERK1 and ERK2 cascade GO:0071230 cellular response to amino acid stimulus GO:0071260 cellular response to mechanical stimulus GO:0071276 cellular response to cadmium ion GO:0071363 cellular response to growth factor stimulus GO:0071364 cellular response to epidermal growth factor stimulus GO:0071392 cellular response to estradiol stimulus GO:0071549 cellular response to dexamethasone stimulus GO:0090263 positive regulation of canonical Wnt signaling pathway GO:0097421 liver regeneration GO:0098609 cell-cell adhesion GO:1900020 positive regulation of protein kinase C activity GO:1901185 negative regulation of ERBB signaling pathway GO:1901224 positive regulation of NIK/NF-kappaB signaling GO:1902722 positive regulation of prolactin secretion GO:1903078 positive regulation of protein localization to plasma membrane GO:1903800 positive regulation of production of miRNAs involved in gene silencing by miRNA GO:1905208 negative regulation of cardiocyte differentiation GO:2000145 regulation of cell motility
U95089 - Human truncated epidermal growth factor receptor-like protein precursor mRNA, complete cds. BC094761 - Homo sapiens epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian), mRNA (cDNA clone MGC:104637 IMAGE:30528231), complete cds. FW403750 - NUCLEIC ACID COMPOUNDS FOR INHIBITING ERBB FAMILY GENE EXPRESSION AND USES THEREOFF. FW403749 - NUCLEIC ACID COMPOUNDS FOR INHIBITING ERBB FAMILY GENE EXPRESSION AND USES THEREOFF. FW403751 - NUCLEIC ACID COMPOUNDS FOR INHIBITING ERBB FAMILY GENE EXPRESSION AND USES THEREOFF. FW403748 - NUCLEIC ACID COMPOUNDS FOR INHIBITING ERBB FAMILY GENE EXPRESSION AND USES THEREOFF. HQ912715 - Homo sapiens epidermal growth factor receptor mRNA, complete cds, alternatively spliced. LP830504 - Sequence 6 from Patent EP3211090. AF125253 - Homo sapiens truncated epidermal growth factor receptor precursor (EGFR) mRNA, complete cds. U48722 - Human epidermal growth factor receptor precursor (EGFR) mRNA, complete cds. X00588 - Human mRNA for precursor of epidermal growth factor receptor. BC070081 - Homo sapiens cDNA clone IMAGE:30346915, containing frame-shift errors. AK225422 - Homo sapiens mRNA for epidermal growth factor receptor isoform a variant, clone: HRC11519. K03193 - Homo sapiens aberrant epidermal growth factor receptor (EGFR) mRNA, complete cds. AB209442 - Homo sapiens mRNA for epidermal growth factor receptor isoform a variant protein. BC134346 - Homo sapiens cDNA clone IMAGE:40082513. AY550966 - Homo sapiens cell growth inhibiting protein 40 mRNA, complete cds. DQ088980 - Homo sapiens cell proliferation-inducing protein 61 mRNA, complete cds. AK290352 - Homo sapiens cDNA FLJ76780 complete cds, highly similar to Homo sapiens epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian) (EGFR), transcript variant 1, mRNA. GU255993 - Homo sapiens epidermal growth factor receptor variant A (EGFR) mRNA, EGFR-S allele, complete cds, alternatively spliced. KJ904454 - Synthetic construct Homo sapiens clone ccsbBroadEn_13848 EGFR gene, encodes complete protein. AY698024 - Homo sapiens epidermal growth factor receptor short isoform (EGFR) mRNA, complete cds. AY698023 - Homo sapiens epidermal growth factor receptor (EGFR) mRNA, partial cds. AB528482 - Synthetic construct DNA, clone: pF1KB4458, Homo sapiens EGFR gene for epidermal growth factor receptor, without stop codon, in Flexi system. AK294750 - Homo sapiens cDNA FLJ55514 complete cds, highly similar to Epidermal growth factor receptor precursor (EC 2.7.10.1). BC057802 - Homo sapiens cDNA clone IMAGE:30337618, with apparent retained intron. MP096126 - Sequence 1 from Patent EP3436584. MP096127 - Sequence 2 from Patent EP3436584. MP096128 - Sequence 3 from Patent EP3436584. MP096129 - Sequence 4 from Patent EP3436584. MP096130 - Sequence 5 from Patent EP3436584. MP096131 - Sequence 6 from Patent EP3436584. MP096132 - Sequence 7 from Patent EP3436584. MP096133 - Sequence 8 from Patent EP3436584. MP096134 - Sequence 9 from Patent EP3436584. MP096135 - Sequence 10 from Patent EP3436584. MP096136 - Sequence 11 from Patent EP3436584. MP096137 - Sequence 12 from Patent EP3436584. MP096138 - Sequence 13 from Patent EP3436584. MP096139 - Sequence 14 from Patent EP3436584. MP096140 - Sequence 15 from Patent EP3436584. MP096141 - Sequence 16 from Patent EP3436584. MP096142 - Sequence 17 from Patent EP3436584. MP096143 - Sequence 18 from Patent EP3436584. MP096144 - Sequence 19 from Patent EP3436584. MP096145 - Sequence 20 from Patent EP3436584. MP096146 - Sequence 21 from Patent EP3436584. MP096147 - Sequence 22 from Patent EP3436584. MP096148 - Sequence 23 from Patent EP3436584. MP096149 - Sequence 24 from Patent EP3436584. MP096150 - Sequence 25 from Patent EP3436584. MP096151 - Sequence 26 from Patent EP3436584. MP096152 - Sequence 27 from Patent EP3436584. MP096153 - Sequence 28 from Patent EP3436584. MP096154 - Sequence 29 from Patent EP3436584. MP096155 - Sequence 30 from Patent EP3436584. MP096156 - Sequence 31 from Patent EP3436584. MP096157 - Sequence 32 from Patent EP3436584. MP096158 - Sequence 33 from Patent EP3436584. MP096159 - Sequence 34 from Patent EP3436584. MP096160 - Sequence 35 from Patent EP3436584. MP096161 - Sequence 36 from Patent EP3436584. MP096162 - Sequence 37 from Patent EP3436584. MP096163 - Sequence 38 from Patent EP3436584. MP096164 - Sequence 39 from Patent EP3436584. MP096165 - Sequence 40 from Patent EP3436584. MP096166 - Sequence 41 from Patent EP3436584. LY639524 - KR 1020180124142-A/76: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639525 - KR 1020180124142-A/77: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639526 - KR 1020180124142-A/78: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639527 - KR 1020180124142-A/79: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639528 - KR 1020180124142-A/80: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639529 - KR 1020180124142-A/81: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639530 - KR 1020180124142-A/82: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639531 - KR 1020180124142-A/83: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639532 - KR 1020180124142-A/84: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639533 - KR 1020180124142-A/85: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639534 - KR 1020180124142-A/86: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639535 - KR 1020180124142-A/87: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639536 - KR 1020180124142-A/88: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639537 - KR 1020180124142-A/89: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639538 - KR 1020180124142-A/90: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639539 - KR 1020180124142-A/91: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639540 - KR 1020180124142-A/92: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639541 - KR 1020180124142-A/93: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639542 - KR 1020180124142-A/94: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639543 - KR 1020180124142-A/95: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639544 - KR 1020180124142-A/96: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639545 - KR 1020180124142-A/97: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639546 - KR 1020180124142-A/98: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639547 - KR 1020180124142-A/99: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639548 - KR 1020180124142-A/100: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639549 - KR 1020180124142-A/101: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639550 - KR 1020180124142-A/102: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639551 - KR 1020180124142-A/103: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639552 - KR 1020180124142-A/104: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639559 - KR 1020180124142-A/111: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639560 - KR 1020180124142-A/112: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639561 - KR 1020180124142-A/113: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639562 - KR 1020180124142-A/114: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639563 - KR 1020180124142-A/115: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639564 - KR 1020180124142-A/116: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122240 - JP 2019513371-A/76: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122241 - JP 2019513371-A/77: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122242 - JP 2019513371-A/78: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122243 - JP 2019513371-A/79: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122244 - JP 2019513371-A/80: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122245 - JP 2019513371-A/81: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122246 - JP 2019513371-A/82: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122247 - JP 2019513371-A/83: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122248 - JP 2019513371-A/84: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122249 - JP 2019513371-A/85: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122250 - JP 2019513371-A/86: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122251 - JP 2019513371-A/87: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122252 - JP 2019513371-A/88: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122253 - JP 2019513371-A/89: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122254 - JP 2019513371-A/90: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122255 - JP 2019513371-A/91: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122256 - JP 2019513371-A/92: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122257 - JP 2019513371-A/93: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122258 - JP 2019513371-A/94: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122259 - JP 2019513371-A/95: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122260 - JP 2019513371-A/96: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122261 - JP 2019513371-A/97: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122262 - JP 2019513371-A/98: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122263 - JP 2019513371-A/99: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122264 - JP 2019513371-A/100: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122265 - JP 2019513371-A/101: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122266 - JP 2019513371-A/102: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122267 - JP 2019513371-A/103: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122268 - JP 2019513371-A/104: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122275 - JP 2019513371-A/111: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122276 - JP 2019513371-A/112: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122277 - JP 2019513371-A/113: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122278 - JP 2019513371-A/114: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122279 - JP 2019513371-A/115: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122280 - JP 2019513371-A/116: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. AK127817 - Homo sapiens cDNA FLJ45919 fis, clone PLACE6001933, moderately similar to Epidermal growth factor receptor precursor (EC 2.7.1.112). AH006650 - Homo sapiens chromosome 7 epidermal growth factor receptor (EGFR) gene, partial cds. X00663 - Human mRNA fragment for epidermal growth factor (EGF) receptor. BC118665 - Homo sapiens epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian), mRNA (cDNA clone IMAGE:40017083), complete cds. BC128419 - Homo sapiens epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian), mRNA (cDNA clone IMAGE:40117840), partial cds. HQ999997 - Homo sapiens epidermal growth factor receptor (EGFR) mRNA, partial cds. EF210210 - Homo sapiens epidermal growth factor receptor variant EX12_14del (EGFR) mRNA, partial cds, alternatively spliced. EF210211 - Homo sapiens epidermal growth factor receptor variant EX12_15del (EGFR) mRNA, partial cds, alternatively spliced. HQ730875 - Homo sapiens epidermal growth factor receptor variant (EGFR) mRNA, partial sequence. CQ894037 - Sequence 37 from Patent WO2004087207. CQ894040 - Sequence 40 from Patent WO2004087207. CQ894043 - Sequence 43 from Patent WO2004087207. CQ894046 - Sequence 46 from Patent WO2004087207. CQ894049 - Sequence 49 from Patent WO2004087207. MF434546 - Homo sapiens SEC61G-EGFR fusion protein (SEC61G-EGFR fusion) mRNA, complete cds. CQ894055 - Sequence 55 from Patent WO2004087207. CQ894058 - Sequence 58 from Patent WO2004087207. MF434547 - Homo sapiens SEC61G-EGFR fusion protein (SEC61G-EGFR fusion) mRNA, complete cds. CQ894061 - Sequence 61 from Patent WO2004087207. AF277897 - Homo sapiens truncated epidermal growth factor receptor (EGFR) mRNA, partial cds; alternatively spliced. CQ894064 - Sequence 64 from Patent WO2004087207. CQ894067 - Sequence 67 from Patent WO2004087207. CQ894070 - Sequence 70 from Patent WO2004087207. HM437234 - Homo sapiens epidermal growth factor receptor variant (EGFR) mRNA, partial cds. DJ418449 - Delivery of Genes Encoding Short Hairpin RNA Using Receptor-Specific Nanocontainers. HM437235 - Homo sapiens nonfunctional epidermal growth factor receptor variant (EGFR) mRNA, partial sequence. JD038391 - Sequence 19415 from Patent EP1572962. JD206630 - Sequence 187654 from Patent EP1572962. JD053648 - Sequence 34672 from Patent EP1572962. JD566190 - Sequence 547214 from Patent EP1572962. JD468402 - Sequence 449426 from Patent EP1572962. JD450262 - Sequence 431286 from Patent EP1572962. JD339715 - Sequence 320739 from Patent EP1572962. JD311355 - Sequence 292379 from Patent EP1572962. JD225552 - Sequence 206576 from Patent EP1572962. JD555874 - Sequence 536898 from Patent EP1572962. JD551162 - Sequence 532186 from Patent EP1572962. JD566195 - Sequence 547219 from Patent EP1572962. JD043551 - Sequence 24575 from Patent EP1572962. JD227437 - Sequence 208461 from Patent EP1572962. JD331919 - Sequence 312943 from Patent EP1572962. JD102582 - Sequence 83606 from Patent EP1572962. JD437158 - Sequence 418182 from Patent EP1572962. JD368376 - Sequence 349400 from Patent EP1572962. JD202027 - Sequence 183051 from Patent EP1572962. JD528038 - Sequence 509062 from Patent EP1572962. JD459433 - Sequence 440457 from Patent EP1572962. JD411327 - Sequence 392351 from Patent EP1572962. LF209004 - JP 2014500723-A/16507: Polycomb-Associated Non-Coding RNAs. GU228573 - Homo sapiens LSINCT1 non-coding RNA, partial sequence. LF325030 - JP 2014500723-A/132533: Polycomb-Associated Non-Coding RNAs. U51732 - Human placenta mRNA, clone PL45, partial sequence. AK026818 - Homo sapiens cDNA: FLJ23165 fis, clone LNG09846. GU228584 - Homo sapiens LSINCT12 non-coding RNA, partial sequence. LF213588 - JP 2014500723-A/21091: Polycomb-Associated Non-Coding RNAs. LF325031 - JP 2014500723-A/132534: Polycomb-Associated Non-Coding RNAs. LF325032 - JP 2014500723-A/132535: Polycomb-Associated Non-Coding RNAs. MA560607 - JP 2018138019-A/132533: Polycomb-Associated Non-Coding RNAs. MA560608 - JP 2018138019-A/132534: Polycomb-Associated Non-Coding RNAs. MA560609 - JP 2018138019-A/132535: Polycomb-Associated Non-Coding RNAs. MA444581 - JP 2018138019-A/16507: Polycomb-Associated Non-Coding RNAs. MA449165 - JP 2018138019-A/21091: Polycomb-Associated Non-Coding RNAs. MP096170 - Sequence 45 from Patent EP3436584. MP096171 - Sequence 46 from Patent EP3436584. MP096172 - Sequence 47 from Patent EP3436584. MP096173 - Sequence 48 from Patent EP3436584. MP096174 - Sequence 49 from Patent EP3436584. MP096175 - Sequence 50 from Patent EP3436584. MP096176 - Sequence 51 from Patent EP3436584. MP096177 - Sequence 52 from Patent EP3436584. MP096178 - Sequence 53 from Patent EP3436584. MP096179 - Sequence 54 from Patent EP3436584. MP096180 - Sequence 55 from Patent EP3436584. MP096181 - Sequence 56 from Patent EP3436584. MP096182 - Sequence 57 from Patent EP3436584. MP096183 - Sequence 58 from Patent EP3436584. MP096184 - Sequence 59 from Patent EP3436584. MP096185 - Sequence 60 from Patent EP3436584. MP096186 - Sequence 61 from Patent EP3436584. MP096187 - Sequence 62 from Patent EP3436584. MP096189 - Sequence 64 from Patent EP3436584. MP096190 - Sequence 65 from Patent EP3436584. MP096191 - Sequence 66 from Patent EP3436584. MP096192 - Sequence 67 from Patent EP3436584. MP096193 - Sequence 68 from Patent EP3436584. MP096194 - Sequence 69 from Patent EP3436584. MP096195 - Sequence 70 from Patent EP3436584. MP096196 - Sequence 71 from Patent EP3436584. MP096197 - Sequence 72 from Patent EP3436584. MP096198 - Sequence 73 from Patent EP3436584. MP096199 - Sequence 74 from Patent EP3436584. MP096200 - Sequence 75 from Patent EP3436584. MP096201 - Sequence 76 from Patent EP3436584. MP096202 - Sequence 77 from Patent EP3436584. MP096203 - Sequence 78 from Patent EP3436584. MP096204 - Sequence 79 from Patent EP3436584. MP096205 - Sequence 80 from Patent EP3436584. MP096206 - Sequence 81 from Patent EP3436584. MP096207 - Sequence 82 from Patent EP3436584. MP096208 - Sequence 83 from Patent EP3436584. MP096209 - Sequence 84 from Patent EP3436584. MP096210 - Sequence 85 from Patent EP3436584. MP096211 - Sequence 86 from Patent EP3436584. MP096212 - Sequence 87 from Patent EP3436584. MP096221 - Sequence 96 from Patent EP3436584. MP096222 - Sequence 97 from Patent EP3436584. MP096223 - Sequence 98 from Patent EP3436584. MP096224 - Sequence 99 from Patent EP3436584. MP096225 - Sequence 100 from Patent EP3436584. MP096226 - Sequence 101 from Patent EP3436584. MP096227 - Sequence 102 from Patent EP3436584. MP096228 - Sequence 103 from Patent EP3436584. MP096229 - Sequence 104 from Patent EP3436584. MP096230 - Sequence 105 from Patent EP3436584. MP096231 - Sequence 106 from Patent EP3436584. MP096232 - Sequence 107 from Patent EP3436584. MP096233 - Sequence 108 from Patent EP3436584. MP096234 - Sequence 109 from Patent EP3436584. MP096235 - Sequence 110 from Patent EP3436584. MP096236 - Sequence 111 from Patent EP3436584. MP096237 - Sequence 112 from Patent EP3436584. MP096238 - Sequence 113 from Patent EP3436584. MP096239 - Sequence 114 from Patent EP3436584. MP096240 - Sequence 115 from Patent EP3436584. MP096241 - Sequence 116 from Patent EP3436584. MP096242 - Sequence 117 from Patent EP3436584. MP096243 - Sequence 118 from Patent EP3436584. MP096244 - Sequence 119 from Patent EP3436584. MP096245 - Sequence 120 from Patent EP3436584. MP096246 - Sequence 121 from Patent EP3436584. MP096247 - Sequence 122 from Patent EP3436584. MP096248 - Sequence 123 from Patent EP3436584. MP096249 - Sequence 124 from Patent EP3436584. MP096250 - Sequence 125 from Patent EP3436584. MP096251 - Sequence 126 from Patent EP3436584. MP096252 - Sequence 127 from Patent EP3436584. MP096253 - Sequence 128 from Patent EP3436584. MP096254 - Sequence 129 from Patent EP3436584. MP096255 - Sequence 130 from Patent EP3436584. MP096256 - Sequence 131 from Patent EP3436584. MP096257 - Sequence 132 from Patent EP3436584. MP096258 - Sequence 133 from Patent EP3436584. MP096259 - Sequence 134 from Patent EP3436584. MP096260 - Sequence 135 from Patent EP3436584. MP096261 - Sequence 136 from Patent EP3436584. MP096262 - Sequence 137 from Patent EP3436584. MP096263 - Sequence 138 from Patent EP3436584. MP096264 - Sequence 139 from Patent EP3436584. MP096265 - Sequence 140 from Patent EP3436584. MP096266 - Sequence 141 from Patent EP3436584. MP096267 - Sequence 142 from Patent EP3436584. MP096268 - Sequence 143 from Patent EP3436584. MP096269 - Sequence 144 from Patent EP3436584. MP096273 - Sequence 148 from Patent EP3436584. MP096274 - Sequence 149 from Patent EP3436584. MP096275 - Sequence 150 from Patent EP3436584. MP096276 - Sequence 151 from Patent EP3436584. MP096277 - Sequence 152 from Patent EP3436584. MP096278 - Sequence 153 from Patent EP3436584. MP096279 - Sequence 154 from Patent EP3436584. MP096280 - Sequence 155 from Patent EP3436584. MP096281 - Sequence 156 from Patent EP3436584. MP096282 - Sequence 157 from Patent EP3436584. MP096283 - Sequence 158 from Patent EP3436584. MP096284 - Sequence 159 from Patent EP3436584. MP096285 - Sequence 160 from Patent EP3436584. MP096286 - Sequence 161 from Patent EP3436584. MP096287 - Sequence 162 from Patent EP3436584. MP096288 - Sequence 163 from Patent EP3436584. MP096289 - Sequence 164 from Patent EP3436584. MP096290 - Sequence 165 from Patent EP3436584. MP096291 - Sequence 166 from Patent EP3436584. MP096292 - Sequence 167 from Patent EP3436584. MP096293 - Sequence 168 from Patent EP3436584. MP096294 - Sequence 169 from Patent EP3436584. MP096295 - Sequence 170 from Patent EP3436584. MP096296 - Sequence 171 from Patent EP3436584. MP096297 - Sequence 172 from Patent EP3436584. MP096298 - Sequence 173 from Patent EP3436584. MP096299 - Sequence 174 from Patent EP3436584. MP096300 - Sequence 175 from Patent EP3436584. MP096301 - Sequence 176 from Patent EP3436584. MP096302 - Sequence 177 from Patent EP3436584. MP096303 - Sequence 178 from Patent EP3436584. MP096304 - Sequence 179 from Patent EP3436584. MP096305 - Sequence 180 from Patent EP3436584. MP096306 - Sequence 181 from Patent EP3436584. MP096307 - Sequence 182 from Patent EP3436584. MP096308 - Sequence 183 from Patent EP3436584. MP096309 - Sequence 184 from Patent EP3436584. MP096310 - Sequence 185 from Patent EP3436584. MP096315 - Sequence 190 from Patent EP3436584. MP096316 - Sequence 191 from Patent EP3436584. MP096317 - Sequence 192 from Patent EP3436584. MP096318 - Sequence 193 from Patent EP3436584. MP096319 - Sequence 194 from Patent EP3436584. MP096320 - Sequence 195 from Patent EP3436584. MP096321 - Sequence 196 from Patent EP3436584. MP096322 - Sequence 197 from Patent EP3436584. MP096323 - Sequence 198 from Patent EP3436584. MP096324 - Sequence 199 from Patent EP3436584. MP096325 - Sequence 200 from Patent EP3436584. MP096326 - Sequence 201 from Patent EP3436584. MP096327 - Sequence 202 from Patent EP3436584. MP096331 - Sequence 206 from Patent EP3436584. MP096332 - Sequence 207 from Patent EP3436584. MP096333 - Sequence 208 from Patent EP3436584. MP096334 - Sequence 209 from Patent EP3436584. MP096335 - Sequence 210 from Patent EP3436584. MP096336 - Sequence 211 from Patent EP3436584. MP096337 - Sequence 212 from Patent EP3436584. MP096348 - Sequence 223 from Patent EP3436584. MP096349 - Sequence 224 from Patent EP3436584. MP096350 - Sequence 225 from Patent EP3436584. MP096351 - Sequence 226 from Patent EP3436584. MP096352 - Sequence 227 from Patent EP3436584. MP096353 - Sequence 228 from Patent EP3436584. MP096354 - Sequence 229 from Patent EP3436584. MP096355 - Sequence 230 from Patent EP3436584. MP096356 - Sequence 231 from Patent EP3436584. MP096357 - Sequence 232 from Patent EP3436584. MP096358 - Sequence 233 from Patent EP3436584. MP096359 - Sequence 234 from Patent EP3436584. MP096360 - Sequence 235 from Patent EP3436584. MP096361 - Sequence 236 from Patent EP3436584. MP096362 - Sequence 237 from Patent EP3436584. MP096363 - Sequence 238 from Patent EP3436584. MP096364 - Sequence 239 from Patent EP3436584. MP096365 - Sequence 240 from Patent EP3436584. MP096366 - Sequence 241 from Patent EP3436584. MP096367 - Sequence 242 from Patent EP3436584. MP096368 - Sequence 243 from Patent EP3436584. MP096369 - Sequence 244 from Patent EP3436584. MP096370 - Sequence 245 from Patent EP3436584. MP096371 - Sequence 246 from Patent EP3436584. MP096372 - Sequence 247 from Patent EP3436584. MP096373 - Sequence 248 from Patent EP3436584. MP096374 - Sequence 249 from Patent EP3436584. MP096375 - Sequence 250 from Patent EP3436584. MP096376 - Sequence 251 from Patent EP3436584. MP096377 - Sequence 252 from Patent EP3436584. MP096378 - Sequence 253 from Patent EP3436584. MP096379 - Sequence 254 from Patent EP3436584. MP096380 - Sequence 255 from Patent EP3436584. MP096381 - Sequence 256 from Patent EP3436584. MP096382 - Sequence 257 from Patent EP3436584. MP096383 - Sequence 258 from Patent EP3436584. MP096384 - Sequence 259 from Patent EP3436584. MP096385 - Sequence 260 from Patent EP3436584. MP096386 - Sequence 261 from Patent EP3436584. MP096387 - Sequence 262 from Patent EP3436584. MP096388 - Sequence 263 from Patent EP3436584. MP096401 - Sequence 276 from Patent EP3436584. MP096402 - Sequence 277 from Patent EP3436584. MP096403 - Sequence 278 from Patent EP3436584. MP096404 - Sequence 279 from Patent EP3436584. MP096405 - Sequence 280 from Patent EP3436584. MP096406 - Sequence 281 from Patent EP3436584. MP096407 - Sequence 282 from Patent EP3436584. MP096408 - Sequence 283 from Patent EP3436584. MP096409 - Sequence 284 from Patent EP3436584. MP096410 - Sequence 285 from Patent EP3436584. MP096411 - Sequence 286 from Patent EP3436584. MP096412 - Sequence 287 from Patent EP3436584. MP096413 - Sequence 288 from Patent EP3436584. MP096414 - Sequence 289 from Patent EP3436584. MP096415 - Sequence 290 from Patent EP3436584. MP096416 - Sequence 291 from Patent EP3436584. MP096417 - Sequence 292 from Patent EP3436584. MP096418 - Sequence 293 from Patent EP3436584. MP096419 - Sequence 294 from Patent EP3436584. MP096420 - Sequence 295 from Patent EP3436584. MP096421 - Sequence 296 from Patent EP3436584. MP096422 - Sequence 297 from Patent EP3436584. MP096423 - Sequence 298 from Patent EP3436584. MP096424 - Sequence 299 from Patent EP3436584. MP096425 - Sequence 300 from Patent EP3436584. MP096426 - Sequence 301 from Patent EP3436584. MP096427 - Sequence 302 from Patent EP3436584. MP096428 - Sequence 303 from Patent EP3436584. MP096429 - Sequence 304 from Patent EP3436584. MP096430 - Sequence 305 from Patent EP3436584. MP096431 - Sequence 306 from Patent EP3436584. MP096432 - Sequence 307 from Patent EP3436584. MP096433 - Sequence 308 from Patent EP3436584. MP096434 - Sequence 309 from Patent EP3436584. MP096435 - Sequence 310 from Patent EP3436584. MP096436 - Sequence 311 from Patent EP3436584. MP096437 - Sequence 312 from Patent EP3436584. MP096438 - Sequence 313 from Patent EP3436584. MP096439 - Sequence 314 from Patent EP3436584. MP096440 - Sequence 315 from Patent EP3436584. MP096441 - Sequence 316 from Patent EP3436584. MP096442 - Sequence 317 from Patent EP3436584. MP096443 - Sequence 318 from Patent EP3436584. MP096444 - Sequence 319 from Patent EP3436584. MP096445 - Sequence 320 from Patent EP3436584. MP096446 - Sequence 321 from Patent EP3436584. MP096447 - Sequence 322 from Patent EP3436584. MP096454 - Sequence 329 from Patent EP3436584. MP096455 - Sequence 330 from Patent EP3436584. MP096456 - Sequence 331 from Patent EP3436584. MP096457 - Sequence 332 from Patent EP3436584. MP096458 - Sequence 333 from Patent EP3436584. MP096459 - Sequence 334 from Patent EP3436584. MP096460 - Sequence 335 from Patent EP3436584. MP096461 - Sequence 336 from Patent EP3436584. MP096462 - Sequence 337 from Patent EP3436584. MP096463 - Sequence 338 from Patent EP3436584. MP096464 - Sequence 339 from Patent EP3436584. MP096465 - Sequence 340 from Patent EP3436584. MP096466 - Sequence 341 from Patent EP3436584. MP096467 - Sequence 342 from Patent EP3436584. MP096468 - Sequence 343 from Patent EP3436584. MP096469 - Sequence 344 from Patent EP3436584. MP096470 - Sequence 345 from Patent EP3436584. MP096471 - Sequence 346 from Patent EP3436584. MP096472 - Sequence 347 from Patent EP3436584. MP096473 - Sequence 348 from Patent EP3436584. MP096474 - Sequence 349 from Patent EP3436584. MP096475 - Sequence 350 from Patent EP3436584. MP096476 - Sequence 351 from Patent EP3436584. MP096477 - Sequence 352 from Patent EP3436584. MP096478 - Sequence 353 from Patent EP3436584. MP096479 - Sequence 354 from Patent EP3436584. MP096480 - Sequence 355 from Patent EP3436584. MP096481 - Sequence 356 from Patent EP3436584. MP096482 - Sequence 357 from Patent EP3436584. MP096492 - Sequence 367 from Patent EP3436584. MP096493 - Sequence 368 from Patent EP3436584. MP096494 - Sequence 369 from Patent EP3436584. MP096495 - Sequence 370 from Patent EP3436584. MP096496 - Sequence 371 from Patent EP3436584. MP096497 - Sequence 372 from Patent EP3436584. MP096498 - Sequence 373 from Patent EP3436584. MP096499 - Sequence 374 from Patent EP3436584. MP096500 - Sequence 375 from Patent EP3436584. MP096501 - Sequence 376 from Patent EP3436584. LY639568 - KR 1020180124142-A/120: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639569 - KR 1020180124142-A/121: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639570 - KR 1020180124142-A/122: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639571 - KR 1020180124142-A/123: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639572 - KR 1020180124142-A/124: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639573 - KR 1020180124142-A/125: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639574 - KR 1020180124142-A/126: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639575 - KR 1020180124142-A/127: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639576 - KR 1020180124142-A/128: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639577 - KR 1020180124142-A/129: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639578 - KR 1020180124142-A/130: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639579 - KR 1020180124142-A/131: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639580 - KR 1020180124142-A/132: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639581 - KR 1020180124142-A/133: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639582 - KR 1020180124142-A/134: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639583 - KR 1020180124142-A/135: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639584 - KR 1020180124142-A/136: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639585 - KR 1020180124142-A/137: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639587 - KR 1020180124142-A/139: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639588 - KR 1020180124142-A/140: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639589 - KR 1020180124142-A/141: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639590 - KR 1020180124142-A/142: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639591 - KR 1020180124142-A/143: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639592 - KR 1020180124142-A/144: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639593 - KR 1020180124142-A/145: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639594 - KR 1020180124142-A/146: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639595 - KR 1020180124142-A/147: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639596 - KR 1020180124142-A/148: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639597 - KR 1020180124142-A/149: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639598 - KR 1020180124142-A/150: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639599 - KR 1020180124142-A/151: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639600 - KR 1020180124142-A/152: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639601 - KR 1020180124142-A/153: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639602 - KR 1020180124142-A/154: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639603 - KR 1020180124142-A/155: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639604 - KR 1020180124142-A/156: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639605 - KR 1020180124142-A/157: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639606 - KR 1020180124142-A/158: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639607 - KR 1020180124142-A/159: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639608 - KR 1020180124142-A/160: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639609 - KR 1020180124142-A/161: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639610 - KR 1020180124142-A/162: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639619 - KR 1020180124142-A/171: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639620 - KR 1020180124142-A/172: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639621 - KR 1020180124142-A/173: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639622 - KR 1020180124142-A/174: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639623 - KR 1020180124142-A/175: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639624 - KR 1020180124142-A/176: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639625 - KR 1020180124142-A/177: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639626 - KR 1020180124142-A/178: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639627 - KR 1020180124142-A/179: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639628 - KR 1020180124142-A/180: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639629 - KR 1020180124142-A/181: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639630 - KR 1020180124142-A/182: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639631 - KR 1020180124142-A/183: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639632 - KR 1020180124142-A/184: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639633 - KR 1020180124142-A/185: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639634 - KR 1020180124142-A/186: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639635 - KR 1020180124142-A/187: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639636 - KR 1020180124142-A/188: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639637 - KR 1020180124142-A/189: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639638 - KR 1020180124142-A/190: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639639 - KR 1020180124142-A/191: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639640 - KR 1020180124142-A/192: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639641 - KR 1020180124142-A/193: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639642 - KR 1020180124142-A/194: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639643 - KR 1020180124142-A/195: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639644 - KR 1020180124142-A/196: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639645 - KR 1020180124142-A/197: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639646 - KR 1020180124142-A/198: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639647 - KR 1020180124142-A/199: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639648 - KR 1020180124142-A/200: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639649 - KR 1020180124142-A/201: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639650 - KR 1020180124142-A/202: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639651 - KR 1020180124142-A/203: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639652 - KR 1020180124142-A/204: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639653 - KR 1020180124142-A/205: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639654 - KR 1020180124142-A/206: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639655 - KR 1020180124142-A/207: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639656 - KR 1020180124142-A/208: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639657 - KR 1020180124142-A/209: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639658 - KR 1020180124142-A/210: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639659 - KR 1020180124142-A/211: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639660 - KR 1020180124142-A/212: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639661 - KR 1020180124142-A/213: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639662 - KR 1020180124142-A/214: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639663 - KR 1020180124142-A/215: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639664 - KR 1020180124142-A/216: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639665 - KR 1020180124142-A/217: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639666 - KR 1020180124142-A/218: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639667 - KR 1020180124142-A/219: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639671 - KR 1020180124142-A/223: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639672 - KR 1020180124142-A/224: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639673 - KR 1020180124142-A/225: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639674 - KR 1020180124142-A/226: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639675 - KR 1020180124142-A/227: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639676 - KR 1020180124142-A/228: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639677 - KR 1020180124142-A/229: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639678 - KR 1020180124142-A/230: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639679 - KR 1020180124142-A/231: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639680 - KR 1020180124142-A/232: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639681 - KR 1020180124142-A/233: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639682 - KR 1020180124142-A/234: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639683 - KR 1020180124142-A/235: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639684 - KR 1020180124142-A/236: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639685 - KR 1020180124142-A/237: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639686 - KR 1020180124142-A/238: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639687 - KR 1020180124142-A/239: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639688 - KR 1020180124142-A/240: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639689 - KR 1020180124142-A/241: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639690 - KR 1020180124142-A/242: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639691 - KR 1020180124142-A/243: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639692 - KR 1020180124142-A/244: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639693 - KR 1020180124142-A/245: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639694 - KR 1020180124142-A/246: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639695 - KR 1020180124142-A/247: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639696 - KR 1020180124142-A/248: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639697 - KR 1020180124142-A/249: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639698 - KR 1020180124142-A/250: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639699 - KR 1020180124142-A/251: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639700 - KR 1020180124142-A/252: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639701 - KR 1020180124142-A/253: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639702 - KR 1020180124142-A/254: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639703 - KR 1020180124142-A/255: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639704 - KR 1020180124142-A/256: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639705 - KR 1020180124142-A/257: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639706 - KR 1020180124142-A/258: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639707 - KR 1020180124142-A/259: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639708 - KR 1020180124142-A/260: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639713 - KR 1020180124142-A/265: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639714 - KR 1020180124142-A/266: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639715 - KR 1020180124142-A/267: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639716 - KR 1020180124142-A/268: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639717 - KR 1020180124142-A/269: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639718 - KR 1020180124142-A/270: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639719 - KR 1020180124142-A/271: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639720 - KR 1020180124142-A/272: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639721 - KR 1020180124142-A/273: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639722 - KR 1020180124142-A/274: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639723 - KR 1020180124142-A/275: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639724 - KR 1020180124142-A/276: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639725 - KR 1020180124142-A/277: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639729 - KR 1020180124142-A/281: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639730 - KR 1020180124142-A/282: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639731 - KR 1020180124142-A/283: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639732 - KR 1020180124142-A/284: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639733 - KR 1020180124142-A/285: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639734 - KR 1020180124142-A/286: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639735 - KR 1020180124142-A/287: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639746 - KR 1020180124142-A/298: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639747 - KR 1020180124142-A/299: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639748 - KR 1020180124142-A/300: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639749 - KR 1020180124142-A/301: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639750 - KR 1020180124142-A/302: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639751 - KR 1020180124142-A/303: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639752 - KR 1020180124142-A/304: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639753 - KR 1020180124142-A/305: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639754 - KR 1020180124142-A/306: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639755 - KR 1020180124142-A/307: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639756 - KR 1020180124142-A/308: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639757 - KR 1020180124142-A/309: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639758 - KR 1020180124142-A/310: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639759 - KR 1020180124142-A/311: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639760 - KR 1020180124142-A/312: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639761 - KR 1020180124142-A/313: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639762 - KR 1020180124142-A/314: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639763 - KR 1020180124142-A/315: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639764 - KR 1020180124142-A/316: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639765 - KR 1020180124142-A/317: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639766 - KR 1020180124142-A/318: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639767 - KR 1020180124142-A/319: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639768 - KR 1020180124142-A/320: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639769 - KR 1020180124142-A/321: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639770 - KR 1020180124142-A/322: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639771 - KR 1020180124142-A/323: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639772 - KR 1020180124142-A/324: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639773 - KR 1020180124142-A/325: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639774 - KR 1020180124142-A/326: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639775 - KR 1020180124142-A/327: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639776 - KR 1020180124142-A/328: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639777 - KR 1020180124142-A/329: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639778 - KR 1020180124142-A/330: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639779 - KR 1020180124142-A/331: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639780 - KR 1020180124142-A/332: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639781 - KR 1020180124142-A/333: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639782 - KR 1020180124142-A/334: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639783 - KR 1020180124142-A/335: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639784 - KR 1020180124142-A/336: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639785 - KR 1020180124142-A/337: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639786 - KR 1020180124142-A/338: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639799 - KR 1020180124142-A/351: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639800 - KR 1020180124142-A/352: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639801 - KR 1020180124142-A/353: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639802 - KR 1020180124142-A/354: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639803 - KR 1020180124142-A/355: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639804 - KR 1020180124142-A/356: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639805 - KR 1020180124142-A/357: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639806 - KR 1020180124142-A/358: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639807 - KR 1020180124142-A/359: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639808 - KR 1020180124142-A/360: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639809 - KR 1020180124142-A/361: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639810 - KR 1020180124142-A/362: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639811 - KR 1020180124142-A/363: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639812 - KR 1020180124142-A/364: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639813 - KR 1020180124142-A/365: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639814 - KR 1020180124142-A/366: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639815 - KR 1020180124142-A/367: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639816 - KR 1020180124142-A/368: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639817 - KR 1020180124142-A/369: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639818 - KR 1020180124142-A/370: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639819 - KR 1020180124142-A/371: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639820 - KR 1020180124142-A/372: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639821 - KR 1020180124142-A/373: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639822 - KR 1020180124142-A/374: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639823 - KR 1020180124142-A/375: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639824 - KR 1020180124142-A/376: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639825 - KR 1020180124142-A/377: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639826 - KR 1020180124142-A/378: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639827 - KR 1020180124142-A/379: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639828 - KR 1020180124142-A/380: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639829 - KR 1020180124142-A/381: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639830 - KR 1020180124142-A/382: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639831 - KR 1020180124142-A/383: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639832 - KR 1020180124142-A/384: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639833 - KR 1020180124142-A/385: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639834 - KR 1020180124142-A/386: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639835 - KR 1020180124142-A/387: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639836 - KR 1020180124142-A/388: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639837 - KR 1020180124142-A/389: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639838 - KR 1020180124142-A/390: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639839 - KR 1020180124142-A/391: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639840 - KR 1020180124142-A/392: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639841 - KR 1020180124142-A/393: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639842 - KR 1020180124142-A/394: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639843 - KR 1020180124142-A/395: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639844 - KR 1020180124142-A/396: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639845 - KR 1020180124142-A/397: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639852 - KR 1020180124142-A/404: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639853 - KR 1020180124142-A/405: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639854 - KR 1020180124142-A/406: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639855 - KR 1020180124142-A/407: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639856 - KR 1020180124142-A/408: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639857 - KR 1020180124142-A/409: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639858 - KR 1020180124142-A/410: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639859 - KR 1020180124142-A/411: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639860 - KR 1020180124142-A/412: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639861 - KR 1020180124142-A/413: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639862 - KR 1020180124142-A/414: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639863 - KR 1020180124142-A/415: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639864 - KR 1020180124142-A/416: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639865 - KR 1020180124142-A/417: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639866 - KR 1020180124142-A/418: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639867 - KR 1020180124142-A/419: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639868 - KR 1020180124142-A/420: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639869 - KR 1020180124142-A/421: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639870 - KR 1020180124142-A/422: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639871 - KR 1020180124142-A/423: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639872 - KR 1020180124142-A/424: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639873 - KR 1020180124142-A/425: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639874 - KR 1020180124142-A/426: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639875 - KR 1020180124142-A/427: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639876 - KR 1020180124142-A/428: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639877 - KR 1020180124142-A/429: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639878 - KR 1020180124142-A/430: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639879 - KR 1020180124142-A/431: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639880 - KR 1020180124142-A/432: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639890 - KR 1020180124142-A/442: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639891 - KR 1020180124142-A/443: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639892 - KR 1020180124142-A/444: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639893 - KR 1020180124142-A/445: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639894 - KR 1020180124142-A/446: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639895 - KR 1020180124142-A/447: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639896 - KR 1020180124142-A/448: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639897 - KR 1020180124142-A/449: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639898 - KR 1020180124142-A/450: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. LY639899 - KR 1020180124142-A/451: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122284 - JP 2019513371-A/120: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122285 - JP 2019513371-A/121: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122286 - JP 2019513371-A/122: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122287 - JP 2019513371-A/123: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122288 - JP 2019513371-A/124: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122289 - JP 2019513371-A/125: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122290 - JP 2019513371-A/126: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122291 - JP 2019513371-A/127: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122292 - JP 2019513371-A/128: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122293 - JP 2019513371-A/129: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122294 - JP 2019513371-A/130: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122295 - JP 2019513371-A/131: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122296 - JP 2019513371-A/132: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122297 - JP 2019513371-A/133: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122298 - JP 2019513371-A/134: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122299 - JP 2019513371-A/135: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122300 - JP 2019513371-A/136: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122301 - JP 2019513371-A/137: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122303 - JP 2019513371-A/139: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122304 - JP 2019513371-A/140: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122305 - JP 2019513371-A/141: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122306 - JP 2019513371-A/142: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122307 - JP 2019513371-A/143: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122308 - JP 2019513371-A/144: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122309 - JP 2019513371-A/145: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122310 - JP 2019513371-A/146: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122311 - JP 2019513371-A/147: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122312 - JP 2019513371-A/148: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122313 - JP 2019513371-A/149: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122314 - JP 2019513371-A/150: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122315 - JP 2019513371-A/151: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122316 - JP 2019513371-A/152: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122317 - JP 2019513371-A/153: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122318 - JP 2019513371-A/154: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122319 - JP 2019513371-A/155: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122320 - JP 2019513371-A/156: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122321 - JP 2019513371-A/157: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122322 - JP 2019513371-A/158: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122323 - JP 2019513371-A/159: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122324 - JP 2019513371-A/160: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122325 - JP 2019513371-A/161: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122326 - JP 2019513371-A/162: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122335 - JP 2019513371-A/171: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122336 - JP 2019513371-A/172: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122337 - JP 2019513371-A/173: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122338 - JP 2019513371-A/174: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122339 - JP 2019513371-A/175: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122340 - JP 2019513371-A/176: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122341 - JP 2019513371-A/177: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122342 - JP 2019513371-A/178: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122343 - JP 2019513371-A/179: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122344 - JP 2019513371-A/180: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122345 - JP 2019513371-A/181: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122346 - JP 2019513371-A/182: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122347 - JP 2019513371-A/183: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122348 - JP 2019513371-A/184: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122349 - JP 2019513371-A/185: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122350 - JP 2019513371-A/186: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122351 - JP 2019513371-A/187: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122352 - JP 2019513371-A/188: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122353 - JP 2019513371-A/189: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122354 - JP 2019513371-A/190: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122355 - JP 2019513371-A/191: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122356 - JP 2019513371-A/192: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122357 - JP 2019513371-A/193: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122358 - JP 2019513371-A/194: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122359 - JP 2019513371-A/195: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122360 - JP 2019513371-A/196: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122361 - JP 2019513371-A/197: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122362 - JP 2019513371-A/198: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122363 - JP 2019513371-A/199: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122364 - JP 2019513371-A/200: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122365 - JP 2019513371-A/201: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122366 - JP 2019513371-A/202: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122367 - JP 2019513371-A/203: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122368 - JP 2019513371-A/204: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122369 - JP 2019513371-A/205: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122370 - JP 2019513371-A/206: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122371 - JP 2019513371-A/207: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122372 - JP 2019513371-A/208: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122373 - JP 2019513371-A/209: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122374 - JP 2019513371-A/210: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122375 - JP 2019513371-A/211: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122376 - JP 2019513371-A/212: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122377 - JP 2019513371-A/213: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122378 - JP 2019513371-A/214: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122379 - JP 2019513371-A/215: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122380 - JP 2019513371-A/216: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122381 - JP 2019513371-A/217: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122382 - JP 2019513371-A/218: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122383 - JP 2019513371-A/219: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122387 - JP 2019513371-A/223: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122388 - JP 2019513371-A/224: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122389 - JP 2019513371-A/225: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122390 - JP 2019513371-A/226: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122391 - JP 2019513371-A/227: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122392 - JP 2019513371-A/228: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122393 - JP 2019513371-A/229: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122394 - JP 2019513371-A/230: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122395 - JP 2019513371-A/231: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122396 - JP 2019513371-A/232: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122397 - JP 2019513371-A/233: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122398 - JP 2019513371-A/234: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122399 - JP 2019513371-A/235: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122400 - JP 2019513371-A/236: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122401 - JP 2019513371-A/237: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122402 - JP 2019513371-A/238: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122403 - JP 2019513371-A/239: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122404 - JP 2019513371-A/240: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122405 - JP 2019513371-A/241: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122406 - JP 2019513371-A/242: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122407 - JP 2019513371-A/243: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122408 - JP 2019513371-A/244: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122409 - JP 2019513371-A/245: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122410 - JP 2019513371-A/246: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122411 - JP 2019513371-A/247: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122412 - JP 2019513371-A/248: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122413 - JP 2019513371-A/249: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122414 - JP 2019513371-A/250: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122415 - JP 2019513371-A/251: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122416 - JP 2019513371-A/252: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122417 - JP 2019513371-A/253: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122418 - JP 2019513371-A/254: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122419 - JP 2019513371-A/255: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122420 - JP 2019513371-A/256: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122421 - JP 2019513371-A/257: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122422 - JP 2019513371-A/258: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122423 - JP 2019513371-A/259: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122424 - JP 2019513371-A/260: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122429 - JP 2019513371-A/265: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122430 - JP 2019513371-A/266: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122431 - JP 2019513371-A/267: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122432 - JP 2019513371-A/268: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122433 - JP 2019513371-A/269: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122434 - JP 2019513371-A/270: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122435 - JP 2019513371-A/271: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122436 - JP 2019513371-A/272: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122437 - JP 2019513371-A/273: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122438 - JP 2019513371-A/274: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122439 - JP 2019513371-A/275: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122440 - JP 2019513371-A/276: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122441 - JP 2019513371-A/277: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122445 - JP 2019513371-A/281: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122446 - JP 2019513371-A/282: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122447 - JP 2019513371-A/283: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122448 - JP 2019513371-A/284: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122449 - JP 2019513371-A/285: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122450 - JP 2019513371-A/286: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122451 - JP 2019513371-A/287: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122462 - JP 2019513371-A/298: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122463 - JP 2019513371-A/299: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122464 - JP 2019513371-A/300: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122465 - JP 2019513371-A/301: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122466 - JP 2019513371-A/302: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122467 - JP 2019513371-A/303: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122468 - JP 2019513371-A/304: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122469 - JP 2019513371-A/305: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122470 - JP 2019513371-A/306: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122471 - JP 2019513371-A/307: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122472 - JP 2019513371-A/308: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122473 - JP 2019513371-A/309: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122474 - JP 2019513371-A/310: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122475 - JP 2019513371-A/311: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122476 - JP 2019513371-A/312: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122477 - JP 2019513371-A/313: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122478 - JP 2019513371-A/314: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122479 - JP 2019513371-A/315: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122480 - JP 2019513371-A/316: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122481 - JP 2019513371-A/317: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122482 - JP 2019513371-A/318: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122483 - JP 2019513371-A/319: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122484 - JP 2019513371-A/320: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122485 - JP 2019513371-A/321: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122486 - JP 2019513371-A/322: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122487 - JP 2019513371-A/323: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122488 - JP 2019513371-A/324: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122489 - JP 2019513371-A/325: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122490 - JP 2019513371-A/326: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122491 - JP 2019513371-A/327: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122492 - JP 2019513371-A/328: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122493 - JP 2019513371-A/329: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122494 - JP 2019513371-A/330: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122495 - JP 2019513371-A/331: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122496 - JP 2019513371-A/332: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122497 - JP 2019513371-A/333: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122498 - JP 2019513371-A/334: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122499 - JP 2019513371-A/335: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122500 - JP 2019513371-A/336: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122501 - JP 2019513371-A/337: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122502 - JP 2019513371-A/338: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122515 - JP 2019513371-A/351: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122516 - JP 2019513371-A/352: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122517 - JP 2019513371-A/353: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122518 - JP 2019513371-A/354: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122519 - JP 2019513371-A/355: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122520 - JP 2019513371-A/356: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122521 - JP 2019513371-A/357: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122522 - JP 2019513371-A/358: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122523 - JP 2019513371-A/359: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122524 - JP 2019513371-A/360: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122525 - JP 2019513371-A/361: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122526 - JP 2019513371-A/362: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122527 - JP 2019513371-A/363: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122528 - JP 2019513371-A/364: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122529 - JP 2019513371-A/365: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122530 - JP 2019513371-A/366: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122531 - JP 2019513371-A/367: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122532 - JP 2019513371-A/368: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122533 - JP 2019513371-A/369: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122534 - JP 2019513371-A/370: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122535 - JP 2019513371-A/371: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122536 - JP 2019513371-A/372: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122537 - JP 2019513371-A/373: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122538 - JP 2019513371-A/374: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122539 - JP 2019513371-A/375: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122540 - JP 2019513371-A/376: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122541 - JP 2019513371-A/377: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122542 - JP 2019513371-A/378: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122543 - JP 2019513371-A/379: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122544 - JP 2019513371-A/380: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122545 - JP 2019513371-A/381: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122546 - JP 2019513371-A/382: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122547 - JP 2019513371-A/383: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122548 - JP 2019513371-A/384: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122549 - JP 2019513371-A/385: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122550 - JP 2019513371-A/386: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122551 - JP 2019513371-A/387: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122552 - JP 2019513371-A/388: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122553 - JP 2019513371-A/389: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122554 - JP 2019513371-A/390: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122555 - JP 2019513371-A/391: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122556 - JP 2019513371-A/392: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122557 - JP 2019513371-A/393: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122558 - JP 2019513371-A/394: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122559 - JP 2019513371-A/395: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122560 - JP 2019513371-A/396: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122561 - JP 2019513371-A/397: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122568 - JP 2019513371-A/404: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122569 - JP 2019513371-A/405: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122570 - JP 2019513371-A/406: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122571 - JP 2019513371-A/407: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122572 - JP 2019513371-A/408: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122573 - JP 2019513371-A/409: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122574 - JP 2019513371-A/410: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122575 - JP 2019513371-A/411: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122576 - JP 2019513371-A/412: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122577 - JP 2019513371-A/413: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122578 - JP 2019513371-A/414: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122579 - JP 2019513371-A/415: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122580 - JP 2019513371-A/416: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122581 - JP 2019513371-A/417: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122582 - JP 2019513371-A/418: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122583 - JP 2019513371-A/419: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122584 - JP 2019513371-A/420: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122585 - JP 2019513371-A/421: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122586 - JP 2019513371-A/422: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122587 - JP 2019513371-A/423: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122588 - JP 2019513371-A/424: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122589 - JP 2019513371-A/425: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122590 - JP 2019513371-A/426: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122591 - JP 2019513371-A/427: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122592 - JP 2019513371-A/428: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122593 - JP 2019513371-A/429: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122594 - JP 2019513371-A/430: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122595 - JP 2019513371-A/431: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122596 - JP 2019513371-A/432: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122606 - JP 2019513371-A/442: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122607 - JP 2019513371-A/443: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122608 - JP 2019513371-A/444: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122609 - JP 2019513371-A/445: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122610 - JP 2019513371-A/446: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122611 - JP 2019513371-A/447: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122612 - JP 2019513371-A/448: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122613 - JP 2019513371-A/449: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122614 - JP 2019513371-A/450: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB122615 - JP 2019513371-A/451: NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF. MB121704 - JP 2019512489-A/68: MICRORNAS AND METHODS OF THEIR USE.
Biochemical and Signaling Pathways
BioCarta from NCI Cancer Genome Anatomy Project h_tffPathway - Trefoil Factors Initiate Mucosal Healing h_agrPathway - Agrin in Postsynaptic Differentiation h_eea1Pathway - The role of FYVE-finger proteins in vesicle transport h_mCalpainPathway - mCalpain and friends in Cell motility h_ErbB3Pathway - Neuroregulin receptor degredation protein-1 Controls ErbB3 receptor recycling h_cblPathway - CBL mediated ligand-induced downregulation of EGF receptors h_keratinocytePathway - Keratinocyte Differentiation h_cardiacegfPathway - Role of EGF Receptor Transactivation by GPCRs in Cardiac Hypertrophy h_spryPathway - Sprouty regulation of tyrosine kinase signals h_telPathway - Telomeres, Telomerase, Cellular Aging, and Immortality h_erkPathway - Erk1/Erk2 Mapk Signaling pathway h_ptenPathway - PTEN dependent cell cycle arrest and apoptosis h_egfPathway - EGF Signaling Pathway h_egfr_smrtePathway - Map Kinase Inactivation of SMRT Corepressor h_At1rPathway - Angiotensin II mediated activation of JNK Pathway via Pyk2 dependent signaling h_her2Pathway - Role of ERBB2 in Signal Transduction and Oncology
Reactome (by CSHL, EBI, and GO)
Protein P00533 (Reactome details) participates in the following event(s):
R-HSA-177942 EGFR binds EGF ligand R-HSA-445069 L1-EGFR trans-heterodimerization R-HSA-1248677 Inactivation of over-expressed wild type EGFR by Cetuximab recombinant antibody R-HSA-1247999 EGFRvIII mutant binds chaperone proteins HSP90 and CDC37. R-HSA-182993 Ubiquitination of stimulated EGFR (CBL) R-HSA-182986 CBL-mediated ubiquitination of CIN85 R-HSA-183036 Ubiquitination of stimulated EGFR (CBL:GRB2) R-HSA-183002 Beta-Pix:CDC42:GTP binds CBL in EGF:p-6Y-EGFR:CBL:CIN85 R-HSA-8867044 EGFR binds EPS15, EPN1, EPS15L1 R-HSA-182994 Assembly of EGFR complex in clathrin-coated vesicles R-HSA-183058 Phosphorylation of CBL (EGFR:GRB2:CBL) R-HSA-183072 EGFR non-clathrin mediated endocytosis R-HSA-183089 CBL binds and ubiquitinates phosphorylated Sprouty R-HSA-182969 Phosphorylation of CBL (EGFR:CBL) R-HSA-177922 EGFR dimerization R-HSA-1977959 ERBB4 forms heterodimers with EGFR R-HSA-8857549 HBEGF-bound EGFR forms a heterodimer with GPNMB R-HSA-1248002 Ligand-independent dimerization of EGFRvIII mutant R-HSA-177925 SHC1 binds to the phosphorylated EGF receptor:ligand complex R-HSA-177941 GRB2:GAB1 binds to phosphorylated EGFR R-HSA-177943 GRB2:SOS1 complex binds to EGF:EGFR complex R-HSA-183055 Binding of CBL to EGFR R-HSA-183067 Localization of CBL:GRB2 to the membrane R-HSA-212706 Phospholipase C-gamma1 binds to the activated EGF receptor R-HSA-8864029 PTPN12 dephosphorylates EGFR at Y1148 (Y1172) R-HSA-9018573 NOTCH3 binds activated EGFR R-HSA-177934 EGFR autophosphorylation R-HSA-177937 Phosphorylation of EGFR by SRC kinase R-HSA-212713 Active PLC-gamma1 dissociates from EGFR R-HSA-9018572 EGFR phosphorylates NOTCH3 R-HSA-8867041 EGFR phosphorylates EPS15 R-HSA-8867047 PTPN3 dephosphorylates EPS15 R-HSA-8951490 CIN85 dissociates from EGF:p-6Y-EGFR:CBL:Beta-Pix:CDC42:GTP:CIN85 R-HSA-183084 CBL escapes CDC42-mediated inhibition by down-regulating the adaptor molecule Beta-Pix R-HSA-182990 Sprouty sequesters CBL away from active EGFR R-NUL-1251923 Plcg1 binds P-ERBB2:P-EGFR R-HSA-2179415 GRB2:SOS1 binds to HBEGF:p-Y-EGFR R-HSA-8866279 Epsin family proteins bind ubiquitinated cargo R-HSA-1225978 Covalent tyrosine kinase inhibitors bind and inhibit wild-type EGF:EGFR dimers R-HSA-1963589 ERBB2 forms heterodimers with ligand-activated ERBB receptors: EGFR, ERBB3 and ERBB4 R-HSA-8857555 EGFR phosphorylates GPNMB R-HSA-8857565 Phosphorylated GPNMB recruits PTK6 and LRRK2 in the presence of LINC01139 R-HSA-1218833 Binding of ligand-responsive EGFR mutants to chaperoning proteins HSP90 and CDC37 R-HSA-1248655 Trans-autophosphorylation of EGFRvIII mutant dimers R-HSA-5637764 Binding of GRB2:GAB1:PIK3R1 complex to p-EGFRvIII mutant R-HSA-5637766 Binding of SHC1 to p-5Y-EGFRvIII R-HSA-5637770 Binding of GRB2:SOS1 complex to phosphorylated EGFRvIII R-HSA-5637792 PLC-gamma 1 binds to p-EGFRvIII mutant R-HSA-5637800 Dissociation of phosphorylated PLC-gamma 1 from p-EGFRvIII mutant R-HSA-177927 PI3K binds to EGF:EGFR:GRB2:GAB1 R-HSA-177944 Activation of SHP2 through the binding to phospho-Gab1 R-HSA-177930 GAB1 phosphorylation by EGFR kinase R-HSA-177933 SHC1 phosphorylation by phosphorylated EGFR R-HSA-177936 GRB2:SOS1 binds to phosphorylated SHC1 in complex with EGFR R-HSA-177924 Dephosphorylation of Gab1 by SHP2 R-HSA-212710 EGFR activates PLC-gamma1 by phosphorylation R-NUL-1251929 Plcg1 phosphorylation by P-ERBB2:P-EGFR R-HSA-1963581 Trans-autophosphorylation of p-Y877-ERBB2 heterodimers R-NUL-1248744 Shc1 binds phosphorylated ERBB2:EGFR heterodimers R-HSA-1250488 GRB2:SOS1 complex binds phosphorylated EGFR:ERBB2 heterodimer R-HSA-1251944 PLCG1 binds to p-ERBB2:p-EGFR R-HSA-1306963 Binding of GRB2:GAB1 to p-ERBB2:p-EGFR R-HSA-8864105 PTPN18 binds ERBB2:EGFR heterodimers R-HSA-1251922 PLCG1 phosphorylation by p-EGFR:p-ERBB2 R-HSA-1963582 Trans-autophosphorylation of ERBB2 heterodimers R-HSA-1963586 SRC family kinases phosphorylate ERBB2 R-HSA-8857577 LINC01139 facilitates PTK6 autophosphorylation R-HSA-177935 SHP2 dephosphorylates Tyr 992 on EGFR R-HSA-1220613 EGF-induced dimerization of ligand-responsive EGFR mutants R-HSA-1220612 Binding of EGF to ligand-responsive EGFR mutants R-HSA-1220614 Spontaneous dimerization of ligand-responsive EGFR mutants R-HSA-5637765 Binding of PI3K p110 subunit alpha (PIK3CA) to complex of GRB2:GAB1:PIK3R1 and p-EGFRvIII R-HSA-5637795 Phosphorylation of PLC-gamma 1 by p-EGFRvIII mutant R-HSA-5637796 Phosphorylation of SHC1 by p-5Y-EGFRvIII R-HSA-5637798 Phosphorylated SHC1 in complex with p-5Y-EGFRvIII recruits GRB2:SOS1 complex R-HSA-177938 SOS1-mediated nucleotide exchange of RAS (EGF:EGFR:GRB2:SOS1) R-HSA-183051 CBL ubiquitinates Sprouty R-HSA-8857925 Inhibition of PP2A activity by phosphorylation of the catalytic subunit at tyrosine Y307 R-HSA-1963563 MATK (CSK homologous kinase) binds phosphorylated ERBB2 R-HSA-1963578 SHC1 binds phosphorylated ERBB2 heterodimers R-HSA-6785636 Phosphorylated ERBB2 heterodimers bind MEMO1 R-HSA-8847995 Activated ERBB2 binds PTK6 (BRK) R-HSA-8863804 PTPN12 dephosphorylates ERBB2 on tyrosine Y1248 R-HSA-8848005 ERBB2 promotes PTK6 autophosphorylation R-HSA-1306965 Binding of PI3K to GRB2:GAB1 in complex with phosphorylated heterodimer of ERBB2 and EGFR. R-HSA-8864125 PTPN18 dephosphorylates ERBB2 at Y1196, Y1112 and Y1248 R-HSA-2179407 SOS1-mediated nucleotide exchange of RAS (HB-EFG-initiated) R-HSA-8867756 CLASP proteins and cargo are recruited to the nascent clathrin-coated pit R-HSA-8857583 LINC01139 promotes phosphorylation of HIF1A by PTK6 and LRRK2 R-HSA-1220611 Covalent tyrosine kinase inhibitors bind and inactivate EGFR kinase domain mutant dimers resistant to non-covalent tyrosine kinase inhibitors R-HSA-1220610 Non-covalent tyrosine kinase inhibitors bind and inactivate sensitive ligand-responsive EGFR cancer mutants R-HSA-5637806 SOS-mediated nucleotide exchange of RAS (mediated by GRB2:SOS1 in complex with p-EGFRvIII) R-HSA-5672965 RAS GEFs promote RAS nucleotide exchange R-HSA-177939 PI3K converts phosphatidylinositol-4,5-bisphosphate (PIP2) to phosphatidylinositol-3,4,5-trisphosphate (PIP3) R-HSA-177923 Sustained activation of SRC kinase by SHP2 R-HSA-177926 Dephosphorylation of PAG by SHP2 R-HSA-177945 SOS1-mediated nucleotide exchange of RAS (EGF:EGFR:SHC1:GRB2:SOS1) R-HSA-1250195 SHC1 phosphorylation by ERBB2 heterodimers R-HSA-1250486 Recruitment of GRB2:SOS1 to p-SHC1 in complex with phosphorylated ERBB2 heterodimers R-HSA-6785648 MEMO1 binds RHOA:GTP:DIAPH1 R-HSA-1250498 RAS guanyl-nucleotide exchange mediated by SOS1 in complex with GRB2 and phosphorylated EGFR:ERBB2 heterodimers. R-HSA-8868071 Clathrin recruits PIK3C2A R-HSA-8868661 Dynamin-mediated GTP hydrolysis promotes vesicle scission R-HSA-8868648 SYNJ hydrolyze PI(4,5)P2 to PI(4)P R-HSA-1225947 Binding of SHC1 to p-6Y-EGFR mutants R-HSA-1225949 Binding of CBL to ligand-responsive p-6Y-EGFR mutants R-HSA-1225950 Binding of GRB2:SOS1 complex to phosphorylated ligand-responsive EGFR mutants R-HSA-1226016 Binding of GRB2:GAB1:PIK3R1 complex to ligand-responsive p-6Y-EGFR mutants R-HSA-1247841 PLCG1 binds to ligand-responsive p-6Y-EGFR mutants R-HSA-1169421 Trans-autophosphorylation of activated ligand-responsive EGFR mutant dimers R-HSA-1247842 Dissociation of phosphorylated PLCG1 from ligand-responsive p-6Y-EGFR mutants R-HSA-5637801 Conversion of PIP2 to PIP3 by PI3K bound to phosphorylated EGFRvIII R-HSA-5637808 SOS-mediated nucleotide exchange of RAS (mediated by GRB2:SOS1 in complex with phosphorylated SHC1 and p-EGFRvIII) R-HSA-8871194 RAB5 and GAPVD1 bind AP-2 R-HSA-8868658 HSPA8-mediated ATP hydrolysis promotes vesicle uncoating R-HSA-8868659 Clathrin recruits auxilins to the clathrin-coated vesicle R-HSA-8868660 Auxilin recruits HSPA8:ATP to the clathrin-coated vesicle R-HSA-2400009 PI3K inhibitors block PI3K catalytic activity R-HSA-2316434 PI3K phosphorylates PIP2 to PIP3 R-HSA-8867754 F- and N- BAR domain proteins bind the clathrin-coated pit R-HSA-8868230 SNX9 recruits components of the actin polymerizing machinery R-HSA-1225961 Phosphorylated SHC1 in complex with ligand-responsive p-6Y-EGFR mutants recruits GRB2:SOS1 complex R-HSA-1225952 Phosphorylation of SHC1 by ligand-responsive p-6Y-EGFR mutants R-HSA-1225960 Phosphorylation of CBL by ligand-responsive p-6Y-EGFR mutants R-HSA-1226012 Binding of PI3K p110 subunit alpha (PIK3CA) to complex of GRB2:GAB1:PIK3R1 and ligand-responsive p-6Y-EGFR mutants R-HSA-1247844 Phosphorylation of PLCG1 by ligand-responsive p-6Y-EGFR mutants R-HSA-1250463 RAS guanyl-nucleotide exchange mediated by SOS1 in complex with GRB2 and p-SHC1:Phosphorylated ERBB2 heterodimers R-HSA-1306957 PIP2 to PIP3 conversion by PI3K bound to GRB2:GAB1 in complex with phosphorylated heterodimer of ERBB2 and EGFR R-HSA-8868072 Clathrin-associated PIK3C2A phosphorylates PI(4)P to PI(3,4)P2 R-HSA-8868236 BAR domain proteins recruit dynamin R-HSA-1225951 SOS-mediated nucleotide exchange of RAS (mediated by GRB2:SOS1 in complex with ligand-responsive p-6Y-EGFR mutants) R-HSA-8868651 Endophilins recruit synaptojanins to the clathrin-coated pit R-HSA-1225957 SOS-mediated nucleotide exchange of RAS (mediated by GRB2:SOS1 in complex with phosphorylated SHC1 and ligand-responsive p-6Y-EGFR mutants) R-HSA-1226014 Conversion of PIP2 to PIP3 by PI3K bound to ligand-responsive p-6Y-EGFR mutants R-HSA-177929 Signaling by EGFR R-HSA-445144 Signal transduction by L1 R-HSA-5638303 Inhibition of Signaling by Overexpressed EGFR R-HSA-2179392 EGFR Transactivation by Gastrin R-HSA-8866910 TFAP2 (AP-2) family regulates transcription of growth factors and their receptors R-HSA-5637810 Constitutive Signaling by EGFRvIII R-HSA-182971 EGFR downregulation R-HSA-1236394 Signaling by ERBB4 R-HSA-8857538 PTK6 promotes HIF1A stabilization R-HSA-9006934 Signaling by Receptor Tyrosine Kinases R-HSA-373760 L1CAM interactions R-HSA-5638302 Signaling by Overexpressed Wild-Type EGFR in Cancer R-HSA-881907 Gastrin-CREB signalling pathway via PKC and MAPK R-HSA-8864260 Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors R-HSA-5637812 Signaling by EGFRvIII in Cancer R-HSA-180336 SHC1 events in EGFR signaling R-HSA-180292 GAB1 signalosome R-HSA-179812 GRB2 events in EGFR signaling R-HSA-212718 EGFR interacts with phospholipase C-gamma R-HSA-9013507 NOTCH3 Activation and Transmission of Signal to the Nucleus R-HSA-8856825 Cargo recognition for clathrin-mediated endocytosis R-HSA-1227986 Signaling by ERBB2 R-HSA-8848021 Signaling by PTK6 R-HSA-162582 Signal Transduction R-HSA-422475 Axon guidance R-HSA-1643713 Signaling by EGFR in Cancer R-HSA-416476 G alpha (q) signalling events R-HSA-212436 Generic Transcription Pathway R-HSA-1236382 Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants R-HSA-9012852 Signaling by NOTCH3 R-HSA-1963640 GRB2 events in ERBB2 signaling R-HSA-1251932 PLCG1 events in ERBB2 signaling R-HSA-1963642 PI3K events in ERBB2 signaling R-HSA-8863795 Downregulation of ERBB2 signaling R-HSA-8856828 Clathrin-mediated endocytosis R-HSA-9006927 Signaling by Non-Receptor Tyrosine Kinases R-HSA-1266738 Developmental Biology R-HSA-5663202 Diseases of signal transduction R-HSA-388396 GPCR downstream signalling R-HSA-73857 RNA Polymerase II Transcription R-HSA-5637815 Signaling by Ligand-Responsive EGFR Variants in Cancer R-HSA-6811558 PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling R-HSA-157118 Signaling by NOTCH R-HSA-1250196 SHC1 events in ERBB2 signaling R-HSA-6785631 ERBB2 Regulates Cell Motility R-HSA-8847993 ERBB2 Activates PTK6 Signaling R-HSA-199991 Membrane Trafficking R-HSA-1643685 Disease R-HSA-372790 Signaling by GPCR R-HSA-74160 Gene expression (Transcription) R-HSA-5673001 RAF/MAP kinase cascade R-HSA-199418 Negative regulation of the PI3K/AKT network R-HSA-5653656 Vesicle-mediated transport R-HSA-5684996 MAPK1/MAPK3 signaling R-HSA-2219530 Constitutive Signaling by Aberrant PI3K in Cancer R-HSA-1257604 PIP3 activates AKT signaling R-HSA-5683057 MAPK family signaling cascades R-HSA-2219528 PI3K/AKT Signaling in Cancer R-HSA-9006925 Intracellular signaling by second messengers
US Server
Sequence and Links to Tools and Databases 
Common Gene Haplotype Alleles 
